Thus, there is a pressing need to find biomarkers that will provide an early diagnosis of AKI, and can be used to risk-stratify patients and follow their course of treatment (Figure 3).

PET imaging using a radiolabeled antibody picked up clear cell renal cell carcinoma and could help avert unnecessary biopsies ...

A study by a team of Chinese researchers highlights the potential of optical coherence tomography angiography (OCTA) in ...

During a Case-Based Roundtable® event, Daniel J. George, MD and participants discussed combination regimens for intermediate ...

A new final rule issued by the Centers for Medicare and Medicaid Services and the U.S. Department of Health and Human ...

A 43-year-old man attended our hospital with a 2-day history of gradually worsening left-sided abdominal pain 6 months after ...

discussing the role of molecular imaging approaches in renal cell carcinoma diagnosis, treatment and response monitoring.

Keywords: acute kidney injury, subcellular mechanisms, blood or urine biomarkers, early diagnosis, transition of AKI to AKD/CKD Important Note: All contributions to this Research Topic must be within ...

A new study published in the International Journal of General Medicine found that a severe vitamin D deficit (<10 ng/mL) ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

A noninvasive urinary biomarker panel predicts lupus nephritis activity and response better than proteinuria, and, if further validated, may aid diagnosis and gauge treatment response, investigators ...